Radiopharmaceuticals: all 1,299 studies that test it
Page 13 of 13. Open to participants first (296), then studies with results posted, then the rest; newest registration first within each.
- FLT-PET in Predicting Response to Chemotherapy in Patients With Advanced MalignanciesCompletedNCT00880074Phase 1
- Study to Evaluate the Efficacy and Safety of Subsequent Treatment With the Zevalin (Ibritumomab Tiuxetan) Study in Patients With Follicular Grade I-II Lymphoma After 4 Cycles of Fludarabine-Mitoxantrone-Rituximab (FMR) TherapyCompletedNCT00859001Phase 2
- Study to Evaluate the Efficacy and Safety of Subsequent Treatment With the Zevalin (Ibritumomab Tiuxetan) in Elderly (More Than 60 Years) Patients With Diffuse Large B Cell Lymphoma After 4 Cycles of CHOP21-Rituximab (CHOP21-R) TherapyCompletedNCT00850512Phase 2
- Clinical Research of Licartin Combined With TACE in the Treatment of Unresectable Hepatocellular CarcinomaCompletedNCT00829465Phase 4
- Fludeoxyglucose F 18 PET/CT Imaging in Finding Cancer in Patients Undergoing Surgery for Solid TumorsCompletedNCT00816335Early Phase 1
- Multi-Tracer PET Assessment of Primary Brain TumorsCompletedNCT00813566Phase 1
- Evaluation of MorphoTEP With the FDG Among Patients in Severe Sepsis of Unspecified EtiologyStatus unknownNCT00791310Phase 3
- Haploidentical Stem Cell Transplantation in NeuroblastomaStatus unknownNCT00790413Early Phase 1
- Zevalin® First Line in Follicular LymphomaStatus unknownNCT00772655Phase 2
- Alpharadin™ (Radium-223 Chloride) Safety and Dosimetry With HRPC That Has Metastasized to the SkeletonCompletedNCT00748046Phase 1
- Phase I Safety and Dosimetry Study in Patients With Confirmed Metastatic MelanomaTerminatedNCT00747825Phase 1
- Exploratory, Phase 0 Study of Positron Emission Tomography (PET) Imaging Agent, F-18 RGD-K5CompletedNCT00743353Early Phase 1
- Selenomethionine in Treating Patients Undergoing Surgery or Internal Radiation Therapy for Stage I or Stage II Prostate CancerWithdrawnNCT00736164Phase 2
- A Safety and Efficacy Study of Intravenous 131I-TM601 in Adult Patients With Malignant MelanomaTerminatedNCT00733798Phase 1/2
- Consolidation Treatment With Y90-Ibritumomab Tiuxetan After R-CHOP Induction in High Risk Patients According to Follicular Lymphoma International Prognostic Index (FLIPI) With Follicular LymphomaStatus unknownNCT00722930Phase 2
- Renal Blood Flow Measurement With Positron Emission Tomography (PET)CompletedNCT00714142Phase 2
- Study to Evaluate the Safety, Pharmacokinetics, Tissue Distribution, Metabolism and Dosimetry of Two Prostate Cancer Imaging AgentsCompletedNCT00712829Phase 1
- A Phase I Study in Healthy Volunteers to Assess Dosimetry and Safety Following Injection of BMS747158 at StressCompletedNCT00707538Phase 1
- A Phase I Study in Healthy Volunteers to Assess Safety of BMS747158CompletedNCT00707499Phase 1
- FDG-Positron Emission Tomography (PET)/CT In the Evaluation of Persistent Febrile Neutropenia in Cancer PatientsTerminatedNCT00707213Phase 1
- Study to Evaluate the Efficacy and Safety of 90Y-SMT487 in Subjects With Symptomatic Malignant Carcinoid TumorsWithdrawnNCT00696930Phase 2
- A Study of 131I-TM601 in Adults With Recurrent Malignant GliomaStatus unknownNCT00683761Phase 1/2
- Dose Confirmation Study of Cotara for the Treatment of Glioblastoma Multiforme at First RelapseCompletedNCT00677716Phase 2
- Targeted Atomic Nano-Generators (Actinium-225-Labeled Humanized Anti-CD33 Monoclonal Antibody HuM195) in Patients With Advanced Myeloid MalignanciesCompletedNCT00672165Phase 1
- PK in Pts With HRPC & Skeletal MetastesCompletedNCT00667537Phase 1
- BAY88-8223, Does Response Study in HRPC PatientsCompletedNCT00667199Phase 2
- ZAR2007: R-CHOP in Folicular Lymphoma Patients no Treated Previously. Consolidation With 90Y Ibritumomab Tiuxetan (Zevalin®) Versus Maintenance Treatment With Rituximab (MabThera®)CompletedNCT00662948Phase 2
- Transplantation With Ybritumomab Tiuxetan (Zevalin) Plus BEAM Regimen in Patients With Refractory Large B-cell Difusse LymphomCompletedNCT00646750Phase 2
- Allogenic Stem Cell Transplantation (SCT) With Non-myeloablative Conditioning in Patients With Relapse Non-Hodgkin's Lymphoma (NHL)CompletedNCT00644371Phase 2
- A Pilot Study of 18F-FLT in Pediatric Patients With Central Nervous System (CNS) TumorsTerminatedNCT00633958Phase 1
- Glioblastoma Multiforme (GBM) Locoregional Agent Survival Study - Anti-tenascin Radiolabeled Antibody TherapyTerminatedNCT00615186Phase 3
- GABA-glutamate Interactions and PsychosisCompletedNCT00611572Phase 1
- Clinical Trial to Assess the Security of the Dose Reduction of Ritonavir in HIV-Infected Patients in Treatment With Tipranavir/Ritonavir 500/200 mg Every 12 HoursCompletedNCT00607958Phase 4
- Safety of Ibritumomab Tiuxetan (Zevalin®) in Combination With a Fludarabine-based Reduced Intensity Conditioning (RIC) Regimen (ZEVALLO 2007)CompletedNCT00607854Phase 2
- Safety and Efficacy Study of Different Doses of 90Y-hPAM4 Combined With Gemcitabine in Pancreatic CancerCompletedNCT00603863Phase 1/2
- Safety and Efficacy Study of 90Y-hPAM4 at Different DosesCompletedNCT00597129Phase 1/2
- 2PX (Topical Strontium Chloride Hexahydrate) in Patients With Post-Amputation Stump Pain.CompletedNCT00592098Phase 2
- Safety and Dose-Finding Study of TM-601 in Adults With Recurrent Malignant GliomaStatus unknownNCT00591058Phase 1
- NM404 as an Imaging Agent in Patients With NSCLCCompletedNCT00582283Phase 1
- Rectal Study: Value of Repeated FDG-PET-CT Scans in Rectal CancerCompletedNCT00576563Not applicable
- Polyethylene Glycol Versus Sodium Phosphate for Colon Preparation After Failure of First Preparation for ColonoscopyTerminatedNCT00558376Not applicable
- A Study of Zevalin and Simultaneous Application of BEAM High-dose Chemotherapy Followed by Autologous Stem Cell Transplantation in Refractory and Relapsed Aggressive Non-Hodgkin LymphomasCompletedNCT00521560Phase 2
- Zevalin-BEAM/BEAC With Autologous Stem Cell Support as Consolidation in First Line Treatment of Mantle Cell LymphomaCompletedNCT00514475Phase 2
- Safety & Radiation Distribution Study of Cotara® in Patients With Recurrent Glioblastoma MultiformeCompletedNCT00509301Phase 1
- Safety Study to Evaluate Induction and Consolidation Treatment in Patients With Mantle Cell Lymphoma (LCM-04-02)CompletedNCT00505232Phase 2
- Zevalin and BEAM High-dose Chemotherapy Compared With BEAM Alone as Conditioning Regimen in Patients With Chemosensitive Relapse of Non-Hodgkin's LymphomaStatus unknownNCT00463463Phase 3
- PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [11C]PBR28 in HIV-Seropositive Patients With (MCMD)TerminatedNCT00459693Not applicable
- A Placebo-controlled Phase II Study of Bone-targeted Radium-223 in Symptomatic Hormone-refractory Prostate CancerCompletedNCT00459654Phase 2
- Safety and Efficacy Study of In-111 Pentetreotide to Treat Neuroendocrine TumorsCompletedNCT00442533Phase 2/3
- Study Combining Zevalin With High-Dose Chemotherapy Prior to Autologous StemCell Transplant in Patients With Relapsed, Refractory, or Transformed Non-Hodgkin's LymphomaStatus unknownNCT00438581Phase 2
- Safety and Efficacy of Bexxar Therapy in the Treatment of Relapsed/Residual B-Cell Lymphoma After Autologous TransplantCompletedNCT00434629Phase 1
- Thyroid-Associated Ophthalmopathy Subtypes and Orbital AntibodiesCompletedNCT00430547Not applicable
- Safety Study of NHL With 90Y-hLL2 IgGCompletedNCT00421395Phase 1/2
- Efficacy and Safety of Treatment With a Single Dose of 90Y-ibritumomab Tiuxetan in Patients With Low Tumor Burden Untreated or Indolent NHLWithdrawnNCT00414089Phase 2
- A Phase I Study in Healthy Volunteers to Evaluate the Safety of CardioPET™ in Detection of Coronary Artery DiseaseCompletedNCT00413647Phase 1
- A Randomized Controlled Trial Comparing Picosalax and Oral Sodium Phosphate for Colon Cleansing Prior to ColonoscopyCompletedNCT00410215Phase 4
- Melphalan, Yttrium Y 90 Ibritumomab Tiuxetan, and Rituximab Followed by Autologous Stem Cell Transplant in Treating Older Patients With Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous TreatmentCompletedNCT00392691Phase 1
- Yt90 Zevalin and Combination Chemotherapy (Z-CHOP)in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-cell LymphomaTerminatedNCT00386321Phase 2
- Fludarabine,Cyclophosphamide and Rituximab Followed by Zevalin for Non-Follicular Indolent Lymphomas.TerminatedNCT00354822Phase 2
- Pharmacokinetic (PK) Study of Single-dose Rosuvastatin and Tipranavir/Ritonavir in Healthy SubjectsCompletedNCT00344123Phase 1
- BAY88-8223, Dose Finding Study in Patients With HRPCCompletedNCT00337155Phase 2
- A Comparative Study Of Iodine I 131 Tositumomab Therapeutic Regimen Versus Ibritumomab Tiuxetan Therapeutic RegimenWithdrawnNCT00319332Phase 3
- Study to Determine the Pharmacokinetic Behavior of Antiretroviral Drugs in Patients Infected by HIVCompletedNCT00307502Phase 1
- 3 TPV/RTV Doses in Multiple ARV Experienced Patients - Tipranavir Dose Defining StudyCompletedNCT00275444Phase 2
- Selenium Treatment in Autoimmune Thyroiditis (AIT)CompletedNCT00271427Not applicable
- Study for Evaluation of Efficacy and Safety of SH L 749 to Indolent B-cell Non-Hodgkin's LymphomaCompletedNCT00220285Phase 2
- Dopamine Transporter Scintigraphy Imaging (DAT-Imaging) in Patients With Lewy Body DementiaCompletedNCT00209456Phase 3
- Rituximab and Chemotherapy Followed by Ibritumomab Tiuxetan as Treatment for Low Grade Follicular Non-Hodgkin's LymphomaCompletedNCT00193440Phase 2
- Zevalin® Followed by Rituxan® Maintenance in Previously Treated Low Grade Non-Hodgkin's LymphomaCompletedNCT00168727Phase 4
- Safety Study of Tipranavir Co-administered With Low-dose Ritonavir (TPV/r) in Patients With Advanced HIV-1 Infection and Limited Treatment OptionsCompletedNCT00144287Phase 3
- Yttrium-90 Ibritumomab Tiuxetan (Zevalin) With BEAM in Relapsed Low Grade B-Cell LymphomaCompletedNCT00138086Phase 2
- Meta-Iodobenzylguanidine (123I mIBG) Scintigraphy in Patients Being Evaluated for Phaeochromocytoma or NeuroblastomaCompletedNCT00126412Phase 3
- Study of Samarium Sm-153 Lexidronam Combined With Docetaxel for Patients With Prostate CancerStatus unknownNCT00121095Phase 1/2
- Chemotherapy Followed by Zevalin for Relapsed Mantle Cell LymphomaCompletedNCT00119730Phase 2
- 131-I-TM-601 Study in Adults With Recurrent High-Grade GliomaStatus unknownNCT00114309Phase 2
- Radiolabeled MAB Therapy in Patients With Refractory, Recurrent, or Advanced CNS or Leptomeningeal CancerTerminatedNCT00089245Phase 1
- Study of Untreated or Transformed Follicular Non-Hodgkin's Lymphoma With Fission-Derived Iodine I 131 TositumomabCompletedNCT00062894Phase 1/2
- Boronophenylalanine-Fructose Complex (BPA-F) and/or Sodium Borocaptate (BSH) Followed By Surgery in Treating Patients With Thyroid Cancer, Head and Neck Cancer, or Liver MetastasesCompletedNCT00062348Phase 1
- Safety and Efficacy of Zevalin in the Treatment of Non-Hodgkin's LymphomaTerminatedNCT00057343Phase 3
- Dual Boosted - Protease Inhibitor (PI) Pharmacokinetics (PK) Trial (Tipranavir / Ritonavir) in Highly Treatment-experienced HIV-1 Infected PatientsCompletedNCT00056641Phase 2
- Safety and Tolerability Study of 131I-TM-601 to Treat Adult Patients With Recurrent Glioma.CompletedNCT00040573Phase 1/2
- Study Of Yttrium-ibritumomab (Zevalin) For the Treatment Of Patients With Relapsed And Refractory Mantle Cell LymphomaCompletedNCT00038623Phase 2
- Assessment of Head and Neck Tumor Hypoxia Using 18F-FluoromisonidazoleWithdrawnNCT00038038Not applicable
- High Dose I-131 Metaiodobenzylguanidine(MIBG) for Metastatic Neuroendocrine TumorsCompletedNCT00037869Phase 3
- Iodine I-131 Iodocholesterol, Its Use in Adrenal ScreeningCompletedNCT00037843Phase 3
- Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Recurrent or Persistent Metastatic Colorectal CancerCompletedNCT00023933Phase 1
- Expanded Access Study of Iodine-131 Anti-B1 AntibodyStatus unknownNCT00022958Not applicable
- Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody Plus CHOP For Untreated Mantle Cell LymphomaCompletedNCT00022945Phase 2
- Safety and Efficacy of Iodine-131 Anti-B1 Antibody for Intermediate Grade Non-Hodgkin's Lymphoma Following First Line CHOPStatus unknownNCT00022932Phase 2
- Safety and Efficacy of Iodine-131 Anti-B1 Antibody for NHL Patients With Greater Than 25% Bone Marrow InvolvementStatus unknownNCT00022906Phase 1
- Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody for the Retreatment of Patients With Non-Hodgkin's LymphomaStatus unknownNCT00022893Not applicable
- Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody for Chronic Lymphocytic LeukemiaStatus unknownNCT00022880Phase 1
- CHP677: I-Metaiodobenzylguanidine (I-MIBG) Therapy for Refractory Neuroblastoma: a Phase II StudyStatus unknownNCT00013806Phase 2
- Liothyronine in Children With Single Ventricle Congenital Cardiac Malformations Undergoing the Fontan ProcedureCompletedNCT00004828Phase 1
- Boron Neutron Capture Therapy Following Surgery in Treating Patients With Glioblastoma Multiforme Removed During SurgeryCompletedNCT00004015Phase 1
- An Ascending, Single Oral Dose Pharmacokinetic Study of 3'-Deoxy-3'-Fluorothymidine (FLT) in Asymptomatic Human Immunodeficiency Virus (HIV)-Infected SubjectsCompletedNCT00002271Not applicable
- An Open-Label, Crossover Study to Assess the Effect of Food on the Oral Bioavailability and Pharmacokinetic Profile of 3'-Deoxy-3'-Fluorothymidine (FLT) in Asymptomatic Human Immunodeficiency Virus (HIV)-Infected SubjectsCompletedNCT00002260Not applicable
- A Multi-Center, Open-Label, Ascending, Multiple Oral Dose, Safety, Tolerance and Pharmacokinetic Study of 3'-Deoxy-3'-Fluorothymidine (FLT) in Patients With Acquired Immune Deficiency Syndrome (AIDS) or AIDS-Related Complex (ARC)CompletedNCT00002254Not applicable
- Phase II Study of the Role of Anti-CEA Antibody Immunoscintigraphy & Positron Emission Tomography in the Localization of Recurrent Colorectal Carcinoma in Patients With Rising Serum CEA Levels in the Absence of Imageable Disease by Conventional ModalitiesCompletedNCT00001568Phase 2